ACP

Acuta Capital Partners Portfolio holdings

AUM $147M
1-Year Est. Return 491.59%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+491.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$147M
AUM Growth
+$50.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$6.2M
2
+$3.1M
3
+$2.63M
4
TNGX icon
Tango Therapeutics
TNGX
+$2.44M
5
DSGN icon
Design Therapeutics
DSGN
+$1.18M

Top Sells

1
+$12.8M
2
+$8.47M
3
+$2.32M
4
ASND icon
Ascendis Pharma
ASND
+$1.95M
5
KRYS icon
Krystal Biotech
KRYS
+$1.87M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TERN icon
1
Terns Pharmaceuticals
TERN
$6.09B
$25.7M 17.48%
637,095
+134,298
PRAX icon
2
Praxis Precision Medicines
PRAX
$9.43B
$24.5M 16.62%
83,036
+33,285
CDTX
3
DELISTED
Cidara Therapeutics
CDTX
$19.7M 13.37%
89,145
-52,384
OCUL icon
4
Ocular Therapeutix
OCUL
$1.93B
$12.8M 8.68%
1,052,995
-112,211
WHWK
5
Whitehawk Therapeutics
WHWK
$180M
$8.25M 5.6%
3,410,402
DRUG
6
Bright Minds Biosciences
DRUG
$869M
$6.59M 4.48%
84,477
-398
CMPX icon
7
Compass Therapeutics
CMPX
$1.01B
$5.87M 3.99%
1,093,300
+253,210
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$12.3B
$4.93M 3.35%
29,008
+3,894
INSM icon
9
Insmed
INSM
$31.9B
$4.5M 3.06%
25,878
-12,714
ARGX icon
10
argenx
ARGX
$52.4B
$4.08M 2.77%
4,851
-1,528
SRZN icon
11
Surrozen
SRZN
$358M
$4.03M 2.74%
178,415
AMLX icon
12
Amylyx Pharmaceuticals
AMLX
$1.87B
$4.03M 2.73%
333,258
NERV icon
13
Minerva Neurosciences
NERV
$271M
$2.85M 1.94%
+709,500
TNGX icon
14
Tango Therapeutics
TNGX
$3.53B
$2.51M 1.7%
+282,732
TSHA icon
15
Taysha Gene Therapies
TSHA
$1.71B
$2.5M 1.7%
454,827
ZYME icon
16
Zymeworks
ZYME
$2.04B
$2.11M 1.43%
80,143
OCS icon
17
Oculis Holding
OCS
$1.6B
$2.03M 1.38%
101,777
DSGN icon
18
Design Therapeutics
DSGN
$780M
$1.42M 0.96%
+150,906
INBX icon
19
Inhibrx
INBX
$1.2B
$1.29M 0.88%
16,377
UTHR icon
20
United Therapeutics
UTHR
$25.5B
$1.12M 0.76%
2,296
VSTM icon
21
Verastem
VSTM
$553M
$1.11M 0.75%
143,446
MAZE
22
Maze Therapeutics
MAZE
$1.34B
$829K 0.56%
+20,000
MLTX icon
23
MoonLake Immunotherapeutics
MLTX
$1.3B
$781K 0.53%
+59,280
STRO icon
24
Sutro Biopharma
STRO
$500M
$780K 0.53%
+67,451
DNTH icon
25
Dianthus Therapeutics
DNTH
$5.19B
$689K 0.47%
16,708
-8,292
1
2